Our team of researchers is a dedicated and diverse team of physicians and allied health professionals with expertise in the treatment of hepatitis C and HIV. Our approach is to identify and effectively treat HIV and hepatitis C with the most up to date therapies and bring the best care and quality in service to our patients. Our research institute has conducted over 100 clinical trials studying the newest therapies available from the leading international biopharmaceutical companies. In these studies we have seen cure rates of certain genotypes of Hepatitis C of greater than 90%. The high quality of our team is based upon scientific discovery, newest technologies and ongoing clinical trial protocols. We are one of few facilities in Los Angeles with FibroScan technology.